Dagny Stuart
-
Study explores how some breast cancers resist treatment
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies. Read MoreApr 21, 2016
-
VICC’s Annual Scientific Retreat set for May 6
Scientists, physicians, staff members and patients interested in the latest in cancer research are invited to attend the Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat to be held Friday, May 6, 8 a.m. – 3 p.m., at the Vanderbilt University Student Life Center. Read MoreApr 21, 2016
-
Free head and neck cancer screening April 15
The symptoms of head and neck cancer can be subtle. To help catch the disease in its earliest stages, the Vanderbilt Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center will offer free head and neck cancer screenings Friday, April 15. Read MoreApr 13, 2016
-
Pietenpol named to NCI Blue Ribbon Panel
Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), has been selected to serve on a Blue Ribbon Panel that will inform the scientific direction and goals at the National Cancer Institute (NCI) for Vice President Joe Biden’s National Cancer Moonshot Initiative. Read MoreApr 7, 2016
-
Annual free screening for head and neck cancer set for April 15
The symptoms of head and neck cancer can be subtle, so to help catch the disease in its earliest stages the Vanderbilt Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center will offer free head and neck screenings Friday, April 15, from 9 a.m. to 3 p.m. Read MoreApr 7, 2016
-
New role identified for p73 gene
The p73 gene is required for the generation of cilia – hair-like projections on cells – findings that could have implications for the study of lung diseases and sterility. Read MoreApr 1, 2016
-
Patient encourages early screening for colon cancer
Vanderbilt-Ingram Cancer Center patient encourages early screening for colon cancer. Read MoreMar 31, 2016
-
VICC to benefit from upcoming Kenny Chesney concert at Auburn
The Chicken Salad Chick Foundation has named Vanderbilt-Ingram Cancer Center as one of the beneficiaries of funds raised at the inaugural Music & Miracles Superfest, featuring singer Kenny Chesney. Read MoreMar 31, 2016
-
Singer’s concert honors care received at Cancer Center
A cancer patient’s gratitude toward his Vanderbilt-Ingram Cancer Center (VICC) physician led to a star-studded concert to benefit the Cancer Center. Read MoreMar 24, 2016
-
T.J. Martell Foundation lauds Pietenpol’s research
Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), was honored with the Medical Research Advancement Award during the 8th Annual T.J. Martell Foundation Nashville Honors Gala held recently at the Omni Nashville Hotel. Read MoreMar 17, 2016
-
Multi-institution cancer symposium set for April 2
The Meharry Medical College, Vanderbilt-Ingram Cancer Center, Tennessee State University Cancer Partnership will host the 15th Annual Cancer Retreat, Saturday, April 2, 8:30 a.m. – 3 p.m. The retreat will be held on the Meharry Medical College campus, Harold D. West Basic Sciences Building, Room M001. Read MoreMar 17, 2016
-
One Million Strong event to raise awareness about colorectal cancer
Thousands of colorectal patients, families and supporters will gather in Nashville April 1 and 2 for the annual One Million Strong event to raise awareness about colorectal cancer. Read MoreMar 17, 2016
-
IOM study calls for better evidence for biomarker tests
Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine. Read MoreMar 10, 2016
-
First VICC cancer patient treated with new immunotherapy
For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system. Read MoreMar 3, 2016
-
Grant spurs research into how cancer cells spread
Aron Parekh, Ph.D., assistant professor of Otolaryngology, has received a four-year, $790,000 Research Scholar Grant from the American Cancer Society to further his research into the mechanical and biological properties of cancer cells and the methods by which they leave the initial tumor and spread or metastasize to other parts of the body. Read MoreMar 3, 2016
-
Chemo better option following pancreatic cancer surgery: study
A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy. Read MoreFeb 25, 2016
-
Creative writing class helps cope with cancer
Receiving a cancer diagnosis and undergoing treatment can be an emotional experience for patients, and their families, friends and caregivers are also affected by the experience. Creative writing can provide an outlet to express and share those strong emotions. Read MoreFeb 18, 2016
-
Warner named medical director of Cancer Registry
Jeremy Warner, M.D., M.S., assistant professor of Medicine and Biomedical Informatics, has been named medical director of the Vanderbilt Cancer Registry at Vanderbilt-Ingram Cancer Center (VICC). Read MoreFeb 11, 2016
-
Annual Pink Out women’s basketball game set for Feb. 14
Pink will be the dominant color in Memorial Gymnasium Sunday, Feb. 14, as the Vanderbilt Commodores Women’s Basketball team participates in the annual Pink Out! game to raise awareness about breast cancer. Read MoreFeb 11, 2016
-
Zutter takes part in cancer strategy meet at White House
Vanderbilt physician/scientist Mary Zutter, M.D., Louise B. McGavock Professor of Pathology, Microbiology and Immunology and assistant vice chancellor for Integrative Diagnostics, can now add “White House guest” to her resume. Read MoreFeb 4, 2016